APA (7th ed.) Citation

L, Z., K, Z., H, Z., J, Z., Y, P., Z, W., . . . B, W. (2019). Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Dove Medical Press.

Chicago Style (17th ed.) Citation

L, Zhang, Zhu K, Zeng H, Zhang J, Pu Y, Wang Z, Zhang T, and Wang B. Resveratrol Solid Lipid Nanoparticles to Trigger Credible Inhibition of Doxorubicin Cardiotoxicity. Dove Medical Press, 2019.

MLA (8th ed.) Citation

L, Zhang, et al. Resveratrol Solid Lipid Nanoparticles to Trigger Credible Inhibition of Doxorubicin Cardiotoxicity. Dove Medical Press, 2019.